CareTrust REIT (CTRE) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
23 Dec, 2025Executive summary
Announced the strategic acquisition of Care REIT plc, a London-listed company, for approximately $856 million, marking entry into the U.K. and the largest deal in company history, with closing expected in May 2025 following shareholder approval.
Net income for Q1 2025 was $65.8 million, or $0.35 per diluted share, up from $28.7 million, or $0.22 per share, in Q1 2024.
Normalized FFO for Q1 2025 reached $77.8 million ($0.42 per share), with a payout ratio of 72%.
99.2% of contractual rent and interest were collected during the quarter.
The acquisition diversifies operator concentration, geography, payer sources, and asset classes, reducing U.S. skilled nursing exposure.
Financial highlights
Q1 2025 revenues were $96.6 million, up from $63.1 million in Q1 2024, driven by higher rental and interest income.
Normalized FFO increased 67.4% year-over-year to $77.8 million; normalized FAD rose 66% to $80.8 million.
Per-share, normalized FFO grew 20% to $0.42, and normalized FAD increased 16.2% to $0.43.
Dividend per share for Q1 2025 was $0.335, with a payout ratio of 78% on normalized FAD.
Gain on sale of real estate in Q1 2025 was $3.9 million from five facility dispositions.
Outlook and guidance
2025 guidance increased: net income projected at $1.36–$1.40 per share, normalized FFO at $1.69–$1.73, and normalized FAD at $1.73–$1.77 per share, assuming no further investments or capital raises this year.
Guidance includes all closed investments to date and assumes CPI rent escalations at 2.5%.
Guidance will be updated after the U.K. transaction closes.
Latest events from CareTrust REIT
- Record capital deployment and performance-driven executive pay defined 2025.CTRE
Proxy filing24 Mar 2026 - Proxy seeks approval for director elections, executive pay, and auditor ratification after a record growth year.CTRE
Proxy Filing13 Mar 2026 - Definitive proxy statement outlines annual meeting proposals and confirms board oversight.CTRE
Proxy Filing13 Mar 2026 - Record 2025 growth and robust 2026 outlook with strong FFO, FAD, and pipeline momentum.CTRE
Q4 20254 Mar 2026 - Double-digit FFO growth, robust investments, and industry-leading returns drive shareholder value.CTRE
Investor presentation2 Mar 2026 - Q2 2024 saw record investments, robust growth, and historic low leverage with strong liquidity.CTRE
Q2 20242 Feb 2026 - Q3 2024 net income hit $33.4M, with record investments and a robust pipeline.CTRE
Q3 202417 Jan 2026 - $817M acquisition of 137 U.K. care homes brings accretion, diversification, and growth.CTRE
M&A Announcement25 Dec 2025 - Record investments and double-digit FFO growth projected for 2025 with low leverage.CTRE
Q4 202419 Dec 2025